Skip to main content

Published locations for Ocrelizumab decreases relapses, brain lesion development in relapsing-remitting MS

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ocrelizumab decreases relapses, brain lesion development in relapsing-remitting MS

User login

  • Reset your password
  • /content/ocrelizumab-decreases-relapses-brain-lesion-development-relapsing-remitting-ms
  • /familypracticenews/article/103615/multiple-sclerosis/ocrelizumab-decreases-relapses-brain-lesion
  • /internalmedicinenews/article/103615/multiple-sclerosis/ocrelizumab-decreases-relapses-brain-lesion
  • /internalmedicine/article/103615/multiple-sclerosis/ocrelizumab-decreases-relapses-brain-lesion
  • /neurology/article/103615/multiple-sclerosis/ocrelizumab-decreases-relapses-brain-lesion-development
  • /familymedicine/article/103615/multiple-sclerosis/ocrelizumab-decreases-relapses-brain-lesion
  • /clinicalneurologynews/article/103615/multiple-sclerosis/ocrelizumab-decreases-relapses-brain-lesion